Evidence map›Paper›PMID 32218609›Full record

ArticleClays and clay minerals2016

Review of Clay-Drug Hybrid Materials for Biomedical Applications: Administration Routes.

Myung Hun Kim, Goeun Choi, Ahmed Elzatahry, Ajayan Vinu, Young Bin Choy, Jin-Ho Choy

Abstract read
In one paragraph

Article in Clays and clay minerals, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. A Review of Pickering Emulsions: Perspectives and Applications.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  11. Review
  12. Review
  13. Review
  14. 2D layered nanomaterials for therapeutics delivery.Current opinion in biomedical engineering · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Gels (Basel, Switzerland) · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Myung Hun Kim14Center for Intelligent Nano-Bio Materials (CINBM), Department of Chemistry and Nano Science, Ewha Womans University, Seoul, 03760 Republic of Korea.
Goeun Choi14Center for Intelligent Nano-Bio Materials (CINBM), Department of Chemistry and Nano Science, Ewha Womans University, Seoul, 03760 Republic of Korea.
Ahmed Elzatahry34Department of Chemistry, King Saud University, 2455, Riyadh 11451, Kingdom of Saudi Arabia.
Ajayan Vinu54Future Industries Institute, University of South Australia, Mawson Lakes, SA Australia.
Young Bin Choy24Interdisciplinary Program in Bioengineering, College of Engineering, Seoul National University, Seoul, 08826 Republic of Korea.
Jin-Ho Choy14Center for Intelligent Nano-Bio Materials (CINBM), Department of Chemistry and Nano Science, Ewha Womans University, Seoul, 03760 Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focus here is placed on the pharmaceutical and biomedical applications of novel clay-drug hybrid materials categorized by methods of administration. Clay minerals have been used for many years as pharmaceutical and medicinal ingredients for therapeutic purposes. A number of studies have attempted to explore clay-drug hybrid materials for biomedical applications with desired functions, such as sustained release, increased solubility, enhanced adsorption, mucoadhesion, biocompatibility, targeting,

Indexed as

Administration MethodsBiocompatibilityBiomedical ApplicationsClay-drug HybridMucoadhesionPharmaceutical ApplicationsSustained ReleaseTargeting

Identifiers

PMID32218609
PMCPMC7091641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.